Document is current

Article History

Received: 20 December 2023

Revised: 20 December 2023

Accepted: 25 January 2024

First Online: 6 March 2024

Declarations

:

: AGOL is the current President of the Pacific Dermatology Association and serves as an associate editor for <i>Dermatology (Karger)</i>. In addition, he is a consultant for Genentech and Guidepoint and an advisor to Bristol Meyer Squibb, Boehringer Ingelheim, and Janssen. AGOL has received research grants from Lilly, Janssen, Incyte, and Pfizer. He is supported by NIH NIAMS R01 AR083110. BES serves on the Advisory Board for Arcutis Biotherapeutics and is an author for UpToDate. Her career is supported by the Dermatology Foundation Medical Career Development Award. AM has received consulting fees from Pfizer, hims, Digital Diagnostics, Concert, Lilly, AbbVie, Equillium, Boehringer Ingelheim, and LEO as well as licensing/royalties from Pfizer, Concert, and Lilly; holds equity in and is on the advisory board for hims and Digital Diagnostics; and has participated in clinical trials related to alopecia from Incyte, Lilly, Concert, and Aclaris while serving as an associate editor for <i>JAMA Dermatology</i>.

: IRB approval by Oregon Health and Science University was granted prior to initiation and was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

: Not applicable.

: Not applicable.